Is It Too Late to Buy Trulieve Cannabis Stock?
It depends on the cannabis operator's ability to continue its remarkable growth.
Got $5,000? 3 Stocks to Buy That Could Double by 2022
Here's how they could do it.
This Late-to-the-Party Coronavirus Vaccine Maker Could Be the Biggest Winner Over the Long Run
Addressing the limitations of the current leading COVID-19 vaccines could be the key to long-term success.
Why AMAG Pharmaceuticals Stock Is Skyrocketing Today
The company is being gobbled up by another drugmaker.
3 Stocks That Look Absurdly Overvalued but Really Aren't
Focusing too much on common valuation metrics can be shortsighted with these high-flying stocks.
The Biggest Coronavirus Vaccine Winner So Far
It isn't even close.
Here's 1 Area Where Aurora Cannabis Absolutely Trounces Canopy Growth
It's really no contest.
Better Buy: GlaxoSmithKline vs. Pfizer
One of these big pharma stocks appears to have an advantage.
Is Moderna Stock a Buy?
The risks are great, but so are the potential rewards.
Better Buy: Invitae vs. Illumina
Which stock wins in this genetics version of David versus Goliath?
Why Axsome Therapeutics Stock Is Sinking Today
An analyst doesn't think very highly of Axsome's prospects.
Why Sorrento Therapeutics Stock Is Surging Today
Investors like the biotech's promising preclinical data for two experimental COVID-19 antibody therapies.
Which Hot IPO Stock Is More Likely to Make You Rich: Amwell or GoodRx?
It's not an easy decision.
Here's When Bill Gates Thinks the Coronavirus Pandemic Will End
Also, here are some stocks that should be good picks before it ends.
Better Buy: Gilead Sciences vs. Amgen
These big biotechs are both moving into new areas. Which is most likely to move the needle for investors?
Why Eiger BioPharmaceuticals Stock Sank Today
The company reported disappointing news from a clinical study targeting COVID-19 outpatients.
Why Inovio Stock Is Crashing Today
The planned phase 2/3 study of COVID-19 vaccine candidate INO-4800 just hit a major speed bump.
Will Marijuana Stocks Soar If Biden Wins and Sink If He Loses?
The answer isn't as clearcut as you might think.
Here's the Bigger Story About Moderna That You Might Be Missing
The biotech's COVID-19 vaccine could be merely the tip of the iceberg.
A Second Wave of Coronavirus Could Be Coming: 3 Stocks to Buy Before It Hits
These stocks are perfectly positioned if the COVID-19 pandemic worsens in the U.S.